Literature DB >> 3537658

[Intermediate results of therapy studies HD1, HD2 and HD3 of the German Hodgkin Study Group].

V Diehl, M Pfreundschuh, F E Hauser, M Löffler, U Rühl, H Brücher, A Georgii, E Hiller, H Gerhartz.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3537658

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN： 0723-5003


× No keyword cloud information.
  2 in total

1.  Chemotherapy of Hodgkin's lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study Group.

Authors:  V Diehl; M Pfreundschuh; M Löffler; U Rühl; E Hiller; H Gerhartz; W Wilmanns; H Kirchner; W Schoppe; S Petsch
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

2.  Prognostic risk factors in advanced Hodgkin's lymphoma. Report of the German Hodgkin Study Group.

Authors:  M Loeffler; M Pfreundschuh; D Hasenclever; E Hiller; H Gerhartz; W Wilmanns; R Rohloff; U Rühl; G Kühn; R Fuchs
Journal:  Blut       Date:  1988-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.